Dignitana is a Swedish medical technology company listed on Nasdaq First North Stockholm.
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB headquarters are in Lund, Sweden with operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy.
Short Name: DIGN
Nasdaq Nordic: Dignitana
Important information about First North
Nasdaq First North is an alternative marketplace run by the various stock exchanges included in Nasdaq. It has the same legal status as a regulated exchange. Companies on Nasdaq First North are regulated by Nasdaq First North’s rules and not by the legal requirements that are demanded for trading on a regulated exchange. An investment in a company that is traded on Nasdaq First North carries more risk than an investment in a company listed on a regulated exchange. All companies, whose stock is listed for trading on Nasdaq First North, have a Certified Advisor who assures that all regulations are observed. Nasdaq Stockholm AB approves applications to be included in trading on Nadaq First North.
The company has appointed Erik Penser as certified advisor.
Erik Penser Bank
+46 (0) 8 463 8000
103 91 Stockholm
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.
10925 Estate Lane, Suite 185
Dallas, TX 75238
226 60 Lund, Sweden
+46 46 16 30 90